Seth M Steinberg Selected Research

Peptides (Polypeptides)

8/2016	TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.
12/2014	Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer.
2/2014	The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors.
1/2010	A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.
11/2007	Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.
11/2005	Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seth M Steinberg Research Topics

Disease

180	Neoplasms (Cancer) 01/2024 - 01/2002
43	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2002
41	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2002
33	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2002
22	Disease Progression 01/2023 - 02/2006
20	Neutropenia 05/2023 - 08/2004
17	Melanoma (Melanoma, Malignant) 11/2017 - 01/2002
16	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2003
14	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2002
14	Lymphoma (Lymphomas) 01/2023 - 04/2002
14	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2002
13	Carcinoma (Carcinomatosis) 01/2024 - 05/2008
12	Mesothelioma 10/2021 - 12/2003
11	Bronchiolitis Obliterans Syndrome 04/2024 - 05/2010
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 12/2006
11	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2022 - 01/2007
10	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 03/2004
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 03/2003
9	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2023 - 05/2014
9	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 04/2002
8	Plexiform Neurofibroma 10/2023 - 05/2014
8	Infections 05/2023 - 02/2007
8	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2009
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2008
8	Vaccinia 05/2012 - 10/2002
7	Adenocarcinoma 01/2024 - 05/2011
7	Fatigue 12/2021 - 05/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2006
7	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 05/2003
7	Ovarian Epithelial Carcinoma 01/2011 - 12/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 05/2010
6	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2008
6	Diarrhea 01/2020 - 05/2002
6	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 02/2007
6	Inflammatory Breast Neoplasms 05/2011 - 12/2002
5	Thrombocytopenia (Thrombopenia) 01/2023 - 11/2014
5	Leukemia 01/2022 - 07/2014
5	Residual Neoplasm 01/2022 - 06/2005
5	Multiple Myeloma 11/2021 - 09/2015
5	Malignant Mesothelioma 10/2021 - 11/2014
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2017 - 06/2003

Drug/Important Bio-Agent (IBA)

31	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2002
28	VaccinesIBA 11/2022 - 10/2002
25	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2002
20	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
19	Docetaxel (Taxotere)FDA Link 01/2021 - 07/2004
18	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 04/2002
17	Bevacizumab (Avastin)FDA Link 11/2022 - 07/2003
17	AntigensIBA 12/2021 - 05/2003
15	Prednisone (Sone)FDA LinkGeneric 01/2021 - 04/2002
15	AndrogensIBA 03/2009 - 10/2002
14	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 10/2002
13	Rituximab (Mabthera)FDA Link 12/2021 - 06/2008
13	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 04/2002
12	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2017
11	Phosphotransferases (Kinase)IBA 10/2023 - 04/2007
11	CytokinesIBA 01/2022 - 08/2002
11	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 04/2002
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2002
10	Immunotoxins (Immunotoxin)IBA 01/2024 - 08/2006
10	MesothelinIBA 01/2024 - 08/2006
10	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 01/2008
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 12/2003
9	PlatinumIBA 10/2023 - 01/2015
9	Chimeric Antigen ReceptorsIBA 01/2023 - 02/2015
9	ErbB Receptors (EGF Receptor)IBA 10/2016 - 08/2004
9	Interleukin-2 (IL2)IBA 02/2014 - 01/2002
8	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2003
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2002
8	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2006
8	romidepsin (FK228)FDA Link 07/2015 - 06/2006
8	VA 061 (VA061)IBA 12/2008 - 07/2004
6	Hormones (Hormone)IBA 01/2021 - 05/2005
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 06/2009
6	Peptides (Polypeptides)IBA 08/2016 - 11/2005
6	DepsipeptidesIBA 06/2011 - 11/2002
6	Thalidomide (Thalomid)FDA Link 04/2010 - 07/2004
5	Sirolimus (Rapamycin)FDA Link 04/2024 - 01/2009
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 03/2003
5	tremelimumabIBA 01/2024 - 01/2017
5	durvalumabIBA 01/2024 - 12/2018
5	AntibodiesIBA 01/2024 - 10/2006
5	AZD 6244IBA 10/2023 - 01/2020
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2023 - 07/2007
5	cediranib (AZD2171)IBA 01/2023 - 06/2013
5	cabozantinibIBA 01/2022 - 09/2015
5	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
5	olaparibIBA 10/2021 - 01/2012
5	PROSTVACIBA 01/2020 - 05/2012

Therapy/Procedure

124	Therapeutics 10/2023 - 01/2002
66	Drug Therapy (Chemotherapy) 04/2024 - 01/2002
19	Immunotherapy 01/2023 - 01/2002
17	Hematopoietic Stem Cell Transplantation 01/2022 - 03/2003
16	Castration 01/2021 - 07/2008
15	Radiotherapy 01/2023 - 08/2003
10	Aftercare (After-Treatment) 01/2024 - 08/2004
7	Neoadjuvant Therapy 04/2024 - 01/2008
6	Transplantation 01/2022 - 03/2003
5	Cell Transplantation 01/2022 - 02/2009